Literature DB >> 2984247

Serotypic characterization of rotaviruses derived from asymptomatic human neonatal infections.

Y Hoshino, R G Wyatt, J Flores, K Midthun, A Z Kapikian.   

Abstract

Nineteen rotavirus strains derived from asymptomatic neonates (seven from England, five from Australia, two from Venezuela, and five from Sweden) were successfully cultivated in primary African green monkey kidney cell cultures, serotyped by plaque reduction neutralization tests, subgrouped by indirect enzyme-linked immunosorbent assay, and electropherotyped by polyacrylamide gel electrophoresis. All 19 strains were shown to fall into one of the four known human serotypes; serotype 1 (all Venezuelan strains), serotype 2 (all Swedish strains), serotype 3 (all Australian strains), or serotype 4 (all English strains). Hyperimmune guinea pig serum raised against the Venezuelan strain (M37) neutralized not only serotype 1 (strain Wa) but also serotype 4 (strain St. Thomas no. 3) viruses to a similar degree. The English, Australian, and Venezuelan isolates were found to belong to subgroup 2, and the Swedish strains were subgroup 1 viruses. The potential importance of these rotaviruses obtained from neonates as possible vaccine candidates is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984247      PMCID: PMC271678          DOI: 10.1128/jcm.21.3.425-430.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  58 in total

1.  Rotavirus shedding by newborn children.

Authors:  I Perez-Schael; G Daoud; L White; G Urbina; N Daoud; M Perez; J Flores
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

2.  Neonatal rotavirus infection: role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protection.

Authors:  B M Totterdell; K G Nicholson; J MacLeod; I L Chrystie; J E Banatvala
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

3.  Unreliability of Rotazyme ELISA test in neonates.

Authors:  P J Krause; J S Hyams; P J Middleton; V C Herson; J Flores
Journal:  J Pediatr       Date:  1983-08       Impact factor: 4.406

4.  Enhancement of human rotavirus infectivity in a monkey kidney cell line by human expressed breast milk.

Authors:  B M Totterdell; J MacLeod; I L Chrystie; J E Banatvala
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

5.  Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies.

Authors:  H Greenberg; V McAuliffe; J Valdesuso; R Wyatt; J Flores; A Kalica; Y Hoshino; N Singh
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Potential spectrum of etiological agents of viral enteritis in hospitalized infants.

Authors:  M Riepenhoff-Talty; L J Saif; H J Barrett; H Suzuki; P L Ogra
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

7.  Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows.

Authors:  L J Saif; D R Redman; K L Smith; K W Theil
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Studies on human lacteal rotavirus antibodies by immune electron microscopy.

Authors:  B M Totterdell; J E Banatvala; I L Chrystie
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

9.  Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

Authors:  R F Bishop; G L Barnes; E Cipriani; J S Lund
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

10.  New opportunities for development of safe, effective live virus vaccines.

Authors:  R M Chanock
Journal:  Yale J Biol Med       Date:  1982 May-Aug
View more
  38 in total

1.  Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001.

Authors:  A R Laird; J R Gentsch; T Nakagomi; O Nakagomi; R I Glass
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Evaluation of three panels of monoclonal antibodies for the identification of human rotavirus VP7 serotype by ELISA.

Authors:  K Y Green; H D James; A Z Kapikian
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Comparison of enzyme immunoassay, PCR, and type-specific cDNA probe techniques for identification of group A rotavirus gene 4 types (P types).

Authors:  P J Masendycz; E A Palombo; R J Gorrell; R F Bishop
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  Cultivation and characterization of rotavirus strains infecting newborn babies in Melbourne, Australia, from 1975 to 1979.

Authors:  M J Albert; L E Unicomb; G L Barnes; R F Bishop
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

5.  Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen.

Authors:  Y Hoshino; L J Saif; M M Sereno; R M Chanock; A Z Kapikian
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

6.  Heterogeneity of genome rearrangements in rotaviruses isolated from a chronically infected immunodeficient child.

Authors:  F Hundley; M McIntyre; B Clark; G Beards; D Wood; I Chrystie; U Desselberger
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

7.  Production and characterization of neutralizing monoclonal antibody to a human rotavirus strain with a "super-short" RNA pattern.

Authors:  J M Tursi; M J Albert; R F Bishop
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

8.  Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988.

Authors:  G M Beards; U Desselberger; T H Flewett
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

9.  Acrylamide concentration affects the relative position of VP7 gene of serotype G2 strains as determined by polyacrylamide gel electrophoresis.

Authors:  Jerri Ross; Eileen N Ostlund; Dianjun Cao; Masatoshi Tatsumi; Yasutaka Hoshino
Journal:  J Clin Virol       Date:  2008-05-23       Impact factor: 3.168

10.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.